Authors:
Santamaria, A
Perez-Severiano, F
Rodriguez-Martinez, E
Maldonado, PD
Pedraza-Chaverri, J
Rios, C
Segovia, J
Citation: A. Santamaria et al., Comparative analysis of superoxide dismutase activity between acute pharmacological models and a transgenic mouse model of Huntington's disease, NEUROCHEM R, 26(4), 2001, pp. 419-424
Citation: N. Cortez et al., Primary astrocytes retrovirally transduced with a tyrosine hydroxylase transgene driven by a glial-specific promoter elicit behavioral recovery in experimental Parkinsonism, J NEUROSC R, 59(1), 2000, pp. 39-46
Citation: F. Perez-severiano et al., Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease, BRAIN RES, 862(1-2), 2000, pp. 234-237
Authors:
Alonso-Pulpon, L
Almenar, L
Crespo, MG
Silva, L
Segovia, J
Manito, N
Cuenca, JJ
Juffe, A
Valles, F
Citation: L. Alonso-pulpon et al., Guidelines of the Spanish Society of Cardiology. Cardiac transplantation and heart-lung transplantation, REV ESP CAR, 52(10), 1999, pp. 821-839
Authors:
Trejo, F
Vergara, P
Brenner, M
Segovia, J
Citation: F. Trejo et al., Biosynthetic capacity of C6 cells engineered with a glial fibrillary acidic protein-tyrosine hydroxylase transgene, MED SCI RES, 27(6), 1999, pp. 423-425
Authors:
Trejo, F
Vergara, P
Brenner, M
Segovia, J
Citation: F. Trejo et al., Gene therapy in a rodent model of Parkinson's disease using differentiatedC6 cells expressing a GFAP-tyrosine hydroxylase transgene, LIFE SCI, 65(5), 1999, pp. 483-491
Citation: J. Segovia et al., Astrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental Parkinsonism, GENE THER, 5(12), 1998, pp. 1650-1655